These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20596674)

  • 21. Cell cycle phase specificity in the potentiation of etoposide-induced DNA damage and apoptosis by KN-62, an inhibitor of calcium-calmodulin-dependent enzymes.
    Aoyama M; Grabowski DR; Holmes KA; Rybicki LA; Bukowski RM; Ganapathi MK; Ganapathi R
    Biochem Pharmacol; 2001 Jan; 61(1):49-54. PubMed ID: 11137708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II.
    Campain JA; Padmanabhan R; Hwang J; Gottesman MM; Pastan I
    J Cell Physiol; 1993 May; 155(2):414-25. PubMed ID: 8097746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells.
    Chiu CC; Li CH; Ung MW; Fuh TS; Chen WL; Fang K
    Cancer Lett; 2005 Jun; 223(2):249-58. PubMed ID: 15896459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topoisomerase II inhibitor-induced apoptosis in thymocytes and lymphoma cells.
    Kizaki H; Onishi Y
    Adv Enzyme Regul; 1997; 37():403-23. PubMed ID: 9381984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines.
    Weiss T; Shalit I; Blau H; Werber S; Halperin D; Levitov A; Fabian I
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1974-82. PubMed ID: 15155187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
    Das CM; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff JE; Gopalakrishnan V
    J Neurooncol; 2007 Nov; 85(2):159-70. PubMed ID: 17534580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
    Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
    Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-inflammatory effects of moxifloxacin on rat airway smooth muscle cells exposed to allergen: Inhibition of extracellular-signal-regulated kinase and nuclear factor-κB activation and of interleukin-8 and eotaxin synthesis.
    Li H; Zhu S; He S; Hao L
    Respirology; 2012 Aug; 17(6):997-1005. PubMed ID: 22616553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.
    Almeida D; Nuermberger E; Tyagi S; Bishai WR; Grosset J
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4261-6. PubMed ID: 17938193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of etoposide induced cell killing by hyperthermia can occur without changes in etoposide transport or DNA topoisomerase II activity.
    Ng CE; Bussey AM; Raaphorst GP
    Int J Hyperthermia; 1996; 12(4):551-67. PubMed ID: 8877478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor.
    Yang F; Chen Y; Duan W; Zhang C; Zhu H; Ding J
    Int J Cancer; 2006 Sep; 119(5):1184-93. PubMed ID: 16570288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
    Chiu CC; Lin CH; Fang K
    Apoptosis; 2005 May; 10(3):643-50. PubMed ID: 15909125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis.
    Inaba M; Mitsuhashi J; Kawada S; Nakano H
    Jpn J Cancer Res; 1994 Feb; 85(2):187-93. PubMed ID: 8144400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
    Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
    Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of G2 arrest on the cytotoxicity of DNA topoisomerase inhibitors toward human carcinoma cells with different p53 status.
    Bozko P; Larsen AK; Raymond E; Skladanowski A
    Acta Biochim Pol; 2002; 49(1):109-19. PubMed ID: 12136930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topoisomerase poisoning by the flavonoid nevadensin triggers DNA damage and apoptosis in human colon carcinoma HT29 cells.
    Müller L; Schütte LRF; Bücksteeg D; Alfke J; Uebel T; Esselen M
    Arch Toxicol; 2021 Dec; 95(12):3787-3802. PubMed ID: 34635930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells.
    Engel R; Valkov NI; Gump JL; Hazlehurst L; Dalton WS; Sullivan DM
    Exp Cell Res; 2004 May; 295(2):421-31. PubMed ID: 15093741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.
    Utsugi T; Aoyagi K; Asao T; Okazaki S; Aoyagi Y; Sano M; Wierzba K; Yamada Y
    Jpn J Cancer Res; 1997 Oct; 88(10):992-1002. PubMed ID: 9414662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo inhibition of etoposide-mediated apoptosis, toxicity, and antitumor effect by the topoisomerase II-uncoupling anthracycline aclarubicin.
    Holm B; Jensen PB; Sehested M; Hansen HH
    Cancer Chemother Pharmacol; 1994; 34(6):503-8. PubMed ID: 7923561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.